Growth Metrics

ADC Therapeutics (ADCT) Inventory Average (2021 - 2023)

Historic Inventory Average for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $21.1 million.

  • ADC Therapeutics' Inventory Average rose 3869.39% to $21.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $21.1 million, marking a year-over-year increase of 3869.39%. This contributed to the annual value of $6.0 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, ADC Therapeutics' Inventory Average stood at $21.1 million, which was up 3869.39% from $18.8 million recorded in Q2 2023.
  • ADC Therapeutics' Inventory Average's 5-year high stood at $21.1 million during Q3 2023, with a 5-year trough of $7863.0 in Q3 2021.
  • Over the past 3 years, ADC Therapeutics' median Inventory Average value was $13.9 million (recorded in 2022), while the average stood at $11.1 million.
  • Per our database at Business Quant, ADC Therapeutics' Inventory Average skyrocketed by 19317864.68% in 2022 and then skyrocketed by 3869.39% in 2023.
  • Quarter analysis of 3 years shows ADC Therapeutics' Inventory Average stood at $4.4 million in 2021, then soared by 218.02% to $13.9 million in 2022, then soared by 51.54% to $21.1 million in 2023.
  • Its Inventory Average stands at $21.1 million for Q3 2023, versus $18.8 million for Q2 2023 and $15.2 million for Q1 2023.